Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04171609 · ClinicalTrials.gov registry record · NA

Expressive Writing for Cancer Survivors

A NA study of Cancer Survivors, sponsored by Duke University.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT04171609 is a NA study of Cancer Survivors that has completed, run by Duke University. The registered enrollment target is 14 participants, below the 116-participant average among 11 other Cancer Survivors trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04171609, a NA study of Cancer Survivors, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Conditions Studied

Interventions

  • BEHAVIORAL Expressive writing

Study Locations (1)

North Carolina

  • Duke Integrative Medicine - Durham

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2019-07-19
Est. Completion 2020-05-14
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04171609

The ClinicalTrials.gov registry entry for NCT04171609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 11 other Cancer Survivors trials with a reported enrollment target (88% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which Expressive writing is the first listed.

NCT04171609 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04171609 about?

NCT04171609 is a clinical study titled "Expressive Writing for Cancer Survivors". The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

What is the current status of trial NCT04171609?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-07-19. Estimated completion is 2020-05-14.

What conditions does trial NCT04171609 study?

This clinical trial studies the following conditions: Cancer Survivors.

What interventions are being tested in trial NCT04171609?

The interventions under investigation include: Expressive writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT04171609?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04171609 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Survivors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.